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Abstract
Notch1 (N1) signaling induced by intrathymic Delta-like (DL) ligands is required for T cell lineage commitment as well as self-
renewal during ‘‘b-selection’’ of TCRb
+ CD4
2CD8
2 double negative 3 (DN3) T cell progenitors. However, over-expression of
the N1 intracellular domain (ICN1) renders N1 activation ligand-independent and drives leukemic transformation during b-
selection. DN3 progenitors also express Notch3 (N3) mRNA, and over-expression of ligand-independent mutant N3 (ICN3)
influences b-selection and drives T cell leukemogenesis. However, the importance of ligand-activated N3 in promoting b-
selection and ICN1-induced T cell leukemogenesis has not been examined. To address these questions we generated mice
lacking functional N3. We confirmed that DN3 progenitors express N3 protein using a N3-specific antibody. Surprisingly
however, N3-deficient DN3 thymocytes were not defective in generating DP thymocytes under steady state conditions or in
more stringent competition assays. To determine if N3 co-operates with N1 to regulate b-selection, we generated N1;N3
compound mutants. However, N3 deficiency did not exacerbate the competitive defect of N1
+/2 DN3 progenitors,
demonstrating that N3 does not compensate for limiting N1 during T cell development. Finally, N3 deficiency did not
attenuate T cell leukemogenesis induced by conditional expression of ICN1 in DN3 thymocytes. Importantly, we showed
that in contrast to N1, N3 has a low binding affinity for DL4, the most abundant intrathymic DL ligand. Thus, despite the
profound effects of ectopic ligand-independent N3 activation on T cell development and leukemogenesis, physiologically
activated N3 is dispensable for both processes, likely because N3 interacts poorly with intrathymic DL4.
Citation: Suliman S, Tan J, Xu K, Kousis PC, Kowalski PE, et al. (2011) Notch3 Is Dispensable for Thymocyte b-Selection and Notch1-Induced T Cell
Leukemogenesis. PLoS ONE 6(9): e24937. doi:10.1371/journal.pone.0024937
Editor: Jose Alberola-Ila, Oklahoma Medical Research Foundation, United States of America
Received July 14, 2011; Accepted August 19, 2011; Published September 13, 2011
Copyright:  2011 Suliman et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by funding from the Canadian Institute for Health Research (CJG: FRN 11530) and Genome Canada Competition III through
the Ontario Genomics Institute (CJG and SEE). SS and JBT were supported by the Research Training Competition fund from the Hospital for Sick Children Research
Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: cynthiaguidos@sickkids.ca
Introduction
Notch signaling is required at multiple stages during T cell
development. There are four mammalian Notch receptor paralogs
(N1-4) that interact with ligands belonging to the Jagged and Delta-
likefamilies(reviewedinRef.[1]).Ligand bindingto Notch receptors
induces gamma secretase-dependent cleavage within the transmem-
brane domain, allowing the released intracellular (ICN) domain to
transit into the nucleus [2]. Nuclear ICN interacts with CSL protein
bound to regulatory regions of Notch target genes, displacing
transcriptional co-repressors and recruiting co-activators to induce
target gene transcription. Delta-like 4 (DL4) and N1 act non-
redundantly to suppress alternative hematopoietic fates of thymus-
seeding progenitors [3–4–5–6–7]. N1 signaling also regulates T cell
specification [8–9–10–11] as well as survival and metabolism [12]
during progression to the DN3a (CD117
2 CD25
+ CD27
lo CD71
lo)
progenitor stage of intrathymic T cell development.
Development of ab T cell progenitors beyond the DN3a stage
requires successful TCRb gene rearrangement and expression of
the pre-TCR complex, comprised of TCRb bound to invariant
pre-Ta and CD3 proteins. Ligand-independent pre-TCR signal-
ing initiates a developmental transition known as b-selection, in
which DN3a progenitors survive, up-regulate expression of CD27,
CD71 (transferrin receptor) and other receptors [13–14–15–16],
and undergo blast transformation in preparation for rapid
proliferation. These lymphoblasts, known as DN3b progenitors,
then clonally expand and differentiate into ab-committed
CD4
+CD8
+ double positive (DP) thymocytes [17–18]. Intermedi-
ates in this transition are known as ‘‘pre-DP’’ thymocytes and
include highly proliferative CD117
2 CD25
2 DN4 cells followed
by CD8 immature single positive (ISP) progenitors [19].
Conditional deletion of N1 from DN3 progenitors severely
compromises generation of DP thymocytes [20], suggesting a non-
redundant role for N1 in b-selection. This role may include
regulation of pre-TCR expression [20–21]. However, Notch
signaling is also required downstream of pre-TCR expression to
induce robust proliferation during the DN3-DP transition [17–22–
23], likely because DL-induced Notch signaling promotes self-
renewal over differentiation during the early stages of b-selection
[16]. Interestingly, although N1
+/2 DN3 progenitors generate
normal numbers of DP thymocytes at steady state, they generate
very few when placed in competition with N1
+/+ DN3 progenitors
[4–5]. Over-expression of Lunatic Fringe, a glycosyltransferase that
enhances N1 binding to DL ligands, ameliorates this competitive
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by DN3 competition for limiting DL ligands in thymic niches [4–5–
18]. This self-renewal role for N1 in thymofcyte b-selection likely
explains why ectopic expression of ligand-independent ICN1 in
DN3progenitors induces T cell lymphoblastic lymphoma/leukemia
(T-LL) in mice [24–25]. Activating N1 mutations are also very
frequent in human T-LL [26], attesting to the power of N1 as an
oncogenic driver of T cell leukemogenesis.
Although N1 non-redundantly regulates T cell specification,
commitment and b-selection, other Notch receptor paralogs are
also expressed in T cell progenitors. Like N1, N2 is required during
embryogenesis [27] and is expressed in hematopoietic stem cells,
DN thymocytes, and CD8 ISP cells [28]. N2 can drive T cell
development from N1-deficient hematopoietic progenitors in
response to DL1 in vitro, but it does not do so intrathymically
[29]. This failure was attributed to poor interaction of N2 with
DL4, the most abundant intrathymic Notch ligand [6–7].
Interestingly, N3 mRNA is sharply up-regulated at the DN3 stage
of T cell development just prior to the onset of b-selection [15],
suggesting it might play a role in this important developmental
process. Indeed, studies of mice expressing ligand-independent
mutant ICN3 in DN3 and pre-DP thymocytes have implicated N3
in regulating pre-Ta expression and in coordinating growth and
differentiation during the DN3-DP transition [30–31–32].
Notch signaling must persist beyond the DN3 stage in order to
sustain self-renewing cell divisions of pre-DP thymocytes through the
early phases of b-selection [16]. Thus, although N1 initiates b-
selection, N3 may act downstream of N1 to regulate survival and
proliferation of pre-DP thymocytes. Indeed, several examples of N1-
N3 co-operation have been reported. For example N3 deficiency in
zebrafish caused defective rhombomere boundary formation in the
central nervous system when N1 was also mutant [33]. N1 and N3
were also reported to interact during esophageal squamous cell
differentiation [34]. Importantly, N3 has been shown to be a direct
transcriptional target of N1 in human T cell leukemia cell lines [35–
36], revealing a potential mechanism for co-operation and suggesting
that N3 may function downstream of N1 in T cell leukemogenesis.
The ability of ectopic N3 activation in DN3 and pre-DP thymocytes
to cause development of T-LL [30] is consistent with this notion.
While studies employing ectopic expression of activated N3 have
been interpreted to suggest that N3 plays an important role in N1-
induced thymocyte b-selection and leukemogenesis, the importance
of physiologically activated N3 in these processes has not been
directly evaluated. Therefore to directly assess the role of N3 in b-
selection and T cell leukemogenesis, we generated N3
LacZ/LacZ mice
that lack functional N3 and express b-galactosidase (LacZ) from the
N3 locus. In N3
LacZ/+ mice, the N3/LacZ reporter was highly
expressed in DN3 progenitors that co-expressed N3 protein.
However, N3 protein was undetectable in N3
LacZ/LacZ DN3
thymocytes, confirming that the N3
LacZ allele abrogates N3
expression. Surprisingly, we detected no impact of N3 deficiency
on b-selection in vitro or in vivo using stringent competition assays.
Furthermore, N3 deficiency did not further reduce the competitive
fitness of N1
+/2 DN3 progenitors, suggesting that N3 does not co-
operate with N1to regulate b-selection.Finally,N3 deficiency did not
alter the incidence or latency of T-LL induced by conditional over-
expression of ICN1 in DN3 and pre-DP thymocytes. We provide
evidence that N3 hasa much lowerbindingaffinityforDL4than N1,
which suggests that N3 may not be physiologically activated by
intrathymic DL4. We conclude that, despite the profound effects of
ligand-independent ectopically expressed ICN3 on T cell develop-
ment and leukemogenesis,physiologicallyactivated N3is dispensable
forthymocyteb-selection and for ICN1-drivenTcellleukemogenesis,
likely because it is not efficiently activated by intrathymic DL4.
Materials and Methods
Mice
N3
LacZ/LacZ mice were generated from embryonic stem cell line
PST033 (BayGenomics, San Francisco, CA) harboring b-geo
(fusion of b-galactosidase and neomycin phosphotransferase)
inserted between exons 16 and 17 of the N3 locus. The mice
were founded on FVB background [37] and backcrossed .15
generations to C57BL/6N (CD45.2). C57BL/6N N1
+/2 mice
have been previously described [5]. Hosts used for adoptive
transfers were B6.CD45.1. Wild-type competitor donors were B6
CD45.1/CD45.2 heterozygous mice. Mice that harbor a floxed
allele of ICN1 knocked into the Rosa26 (R26) locus have been
previously described [38]. R26-ICN1
lox/+ mice were crossed to Lck-
Cre transgenic mice as previously described [16]. All mice were
bred in a specific pathogen-free facility at the Toronto Centre for
Phenogenomics. Intrathymic injections were performed on
anesthetized, sub-lethally irradiated (650 cGy) B6.CD45.1 mice
(6–8 weeks old) as previously described [5]. All animal protocols
were approved by Institutional Animal Care Committees at the
Hospital for Sick Children; permit number: 6350 (Toronto,
Canada), and the Toronto Centre for Phenogenomics; permit
number: 12-04-0053-H (Toronto, Canada). Genotypes were
determined by PCR amplification of tail DNA.
Magnetic Bead Depletions
Thymocytes were stained with rat IgG antibodies specific for
CD4 (clone YTS 191.1), CD8 (clone YTS 169.4), CD3 (clone 145-
2C11), B220 (clone RA3 6B2), Mac-1 (M1/70), Gr-1 (RB6-8C5),
and TER119 and cells expressing these lineage markers were
depleted using goat anti-rat IgG magnetic microbeads as per the
Miltenyi Biotec protocol, using an AutoMACS Pro Separator
(Miltenyi Biotec, Cologne, Germany). Bone marrow (BM) cells
were enriched for stem cells and lineage-negative (Lin
2)
progenitors by magnetic depletion of cells expressing CD5,
CD11b, B220, 7-4, Gr-1, or TER119 using the Miltenyi Biotec
Lineage Cell Depletion Kit as per the manufacturer’s protocol.
Flow Cytometry
Thymocyte single cell suspensions were made and viable cell
counts determined by trypan blue exclusion. Cells were suspended
in staining media and stained as previously described [5] with
saturating concentrations of fluorochrome-conjugated antibodies
(listed below). Fluorescence was analyzed using a BD (Becton
Dickinson, San Jose, CA) LSR-II flow cytometer equipped with 4
solid-state lasers: 488nm (100 mW), 633 nm (20 mW), 405nm
(25 mW) and 350 nm (20 mW). To analyze DN thymocyte
subsets, Lin
2 thymocytes were stained with saturating concentra-
tions of flurochrome-conjugated antibodies specific for CD25
(clone 7D4) and CD117 (clone 2B8). FCS 3.0 data files were
analyzed using FlowJo Versions 8.6–9.3 (Tree Star, Ashland, OR).
Debris and dead cells were gated out based on low forward scatter
(FSC) and high propidium iodide staining.
Analysis of N3/LacZ Reporter Expression
b-galactosidase (LacZ) expression was detected using the
Fluorescein di-b-D-galactopyranoside (FDG, Molecular Probes,
Eugene, OR) substrate containing fluorescein isothiocyanate
(FITC) linked to each galactose moiety, which quenches FITC
fluorescence. Following enzymatic cleavage of galactose by b-
galactosidase, the FITC is released from the N3/LacZ reporter
and the unquenched FITC fluorescence was quantified by flow
cytometry. Single cell suspensions of total or Lin
2 DN thymocytes
were hypotonically shocked to allow the entry of 2 mM FDG for
N3 Function in Thymopoiesis and Leukemogenesis
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subsequently stained with fluorochrome-conjugated antibodies.
Antibody Fluorochrome Conjugates
Anti-CD4-Allophycocyanin (APC, clone GK1.5), anti-CD8-
eFluor650 nano-crystal (NC, clone 53–6.7), anti-CD45.1-PE-Cy7
(clone A20), and anti-CD45.2-FITC (clone 104) were purchased
from eBioScience, San Diego. Anti-CD8-Phycoerythrin (PE, clone
53–6.7), anti-CD25 conjugated to FITC and APC (clone 7D4),
anti-CD117-APC-Cy7 (clone 2B8), anti-CD71 conjugated to PE
or biotin (clone C2), avidin-PE-Cy5, and anti-TCRb-APC (clone
H57-597) were purchased from BD Biosciences, San Jose, CA.
Anti-CD4-Pacific Blue (clone RM4–5) was purchased from
Invitrogen (Carlsbad, CA). Anti-mouse Notch3-PE (clone
HMN3-133) and anti-human Notch3-PE (clone MHN3-21) were
both purchased from BioLegend, San Diego. Polyclonal goat anti-
human IgG-Fc conjugated to PE (Cedarlane, ON).
Notch Ligand Binding Assay
To over-express N1, 293T human embryonic kidney cells were
transiently transfected with pEGFP-N1-Notch1 encoding full-
length murine N1 fused in-frame to GFP at the C-terminus [29].
To over-express N3, 293T cells were co-transfected with plasmids
encoding human N3 with a C-terminal Myc tag (pCDNA4-His-
Myc-A-hNotch3) and pmaxFP-Green-N (pMAX-GFP) from
Amaxa-Lonza (Walkersville, MD). Transfections were performed
using FuGene (Roche, Mississauga) accordingto the manufacturer’s
protocol. After 72 hrs, flow cytometry was used to assess
transfectants for binding of control hFc versus DL4-Fc (kindly
provided by Dr. Freddy Radtke) fusion proteins as previously
described [29]. Surface expression of N3 on GFP versus N3-
Myc+GFP transfectants was evaluated by flow cytometry using an
anti-human N3 Ab as described above. In addition, whole cell
lysates from transfected and control untransfected 293T cells were
prepared using RIPA buffer (50mM Tris-HCl, 1% NP-40, 0.25%
Sodium deoxycholate, 150mM NaCl, 1mM EDTA pH 7.4) and
protease inhibitors (1mM sodium vanadate and 1mM sodium
fluoride). 10 mg of each lysate was used for immunoblotting with
anti-human c-Myc monoclonal antibody clone 9E10 (Cedarlane
Laboratories Ltd, Burlington, ON) and rabbit polyclonal anti-b-
actin antibody, was purchased from Sigma-Aldrich (St. Louis, MO).
In Vitro T Cell Differentiation
DN3 (Lin
2 CD117
2 CD25
+) progenitors from each genotype
weresorted directlyinto24-wellplates(2610
3/well)containingOP9-
DL4 stromal cells [16] (2610
4/well plated the previous day) and
cultured for 3 or 6 days as previously described [16]. After each time
point viable cell counts were determined by trypan blue exclusion
and expression of CD4 and CD8 was assessed by flow cytometry.
Characterization of T-Lymphoblastic Leukemia (T-LL)
Cohorts of N3
+/+ R26-ICN1
lox/+;Lck-Cre
+ vs N3
LacZ/LacZ R26-
ICN1
lox/+;Lck-Cre
+ mice were aged until they became moribund and
showed clinical signs of leukemia, such as scruffiness, distended
abdomen,and/orlethargy.Livers,kidneysand spleenswere fixedin
4% formaldehyde and processed for hematoxylin and eosin staining
using standard procedures. Thymi, spleens, lymph nodes and bone
marrow (BM) of moribund mice were explanted and analyzed for
expression of GFP and TCRb using flow cytometry as described
above. To determine if the T cell leukemias were transplantable,
3X10
6 GFP
+ cells were sorted from spleen and lymph nodes of
moribund mice and injected intravenously into sub-lethally
irradiated (650 cGy) RAG2
2/2; Ly5.2 hosts. Leukemic burden was
assessed 2 and 4 weeks later using flow cytometry to evaluate the
abundance of GFP
+ TCRb leukemic blasts in spleen, lymph nodes
and bone marrow of injected mice.
Statistical Methods
For all experiments, two-tailed unpaired Student T-test with
Welch’s correction (assuming unequal variances) was used with a
95% confidence interval for pair-wise comparisons between
different genotypes. For Kaplan-Meier survival curves, Student T-
test used to compare the difference in the survival between the two
groups. The median survival of each genotype was also calculated.
All statistical analyses were performed using Prism software (V4.0).
Results
DN3 thymocytes from N3
LacZ/LacZ mice lack N3 expression
To study N3 expression and function in T cell development, we
generated mice from embryonic stems cells in which N3 is fused in
frame with b-galactosidase (LacZ), generating a null allele of N3
and a reporter for N3 gene expression [37–39]. Upon challenge,
N3
LacZ/LacZ mice show increased susceptibility to ischemic stroke
[40], but when unperturbed they appear normal and healthy,
allowing us to determine how loss of N3 function impacts T cell
development. We employed a sensitive fluorogenic substrate to
detect N3/LacZ reporter expression in progenitors just before and
after the b-selection checkpoint. Interestingly, N3/LacZ expres-
sion was higher in DN3a (CD71
lo) than in CD71
hi DN3b
thymocytes from N3
LacZ/+ mice (Fig. 1A, top), in keeping with a
similar decline in N3 mRNA during this transition [15–41].
However, background levels of auto-fluorescence were higher in
DN3b thymocytes (Fig. 1A, bottom). Therefore, in order to
directly compare changes in N3/LacZ reporter expression
between subsets, we normalized fluorescence intensities of
N3
LacZ/+ cells to the background fluorescence of N3
+/+ cells for
each subset. Comparing these normalized ratios revealed that on
average, N3/LacZ expression was highest in DN3a cells and
declined 3-4-fold in DN3b thymocytes.
Importantly, these subtle changes in N3/LacZ reporter
expression are highly correlated with previously reported changes
in N3 mRNA expression across this transition [15–41], revealing
that N3/LacZ ‘‘reports’’ N3 expression accurately. Furthermore,
N3 protein was most highly expressed on DN2 and DN3
thymocytes from N3
+/+ mice, but declined dramatically by the
DN4 stage (Fig. 1B) and was not detected on DP thymocytes (data
not shown). Thus, similar to N3 mRNA [15–41], expression of N3
protein is sharply induced just prior to the b-selection checkpoint
but declines precipitously thereafter.
Prior studies have demonstrated that the N3
LacZ allele does not
produce detectable levels of mRNA or protein [39–40–42].
Furthermore, N3
LacZ/LacZ mice exhibit vascular smooth muscle
defects[40],confirming loss of N3function inthesemice. Weused a
N3-specific antibody to examine N3 protein expression in
thymocytes from N3
LacZ/LacZ mice. N3 protein expression was
slightly lower in all subsets from N3
LacZ/+ mice indicating a gene
dosage effect (Fig. 1B). Importantly, we could not detect N3 protein
expression on any thymocyte subsets from N3
LacZ/LacZ mice (Fig. 1B
and data not shown). Thus, N3 protein is highly expressed in DN3
thymocytes from N3
+/+ and N3
LacZ/+ but not N3
LacZ/LacZ mice.
N3 is dispensable for thymic development at steady state
and in competition with N3
+/+ DN3 progenitors
To determine if N3 deficiency impacts b-selection, we analyzed
the relative and absolute numbers of intrathymic T cell
progenitors in N3
+/+ and N3
LacZ/LacZ littermates. Although another
N3 Function in Thymopoiesis and Leukemogenesis
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thymic cellularity at 10-weeks of age [43], we did not observe
lower percentages or absolute numbers of DN, or post-b-selection
subsets at steady state in C57BL6 N3
LacZ/LacZ relative to N3
+/+
mice at either 3 or 10 weeks of age (Fig. 2).
Competition amongst DN3 progenitors for DL Notch ligands
in thymic niches regulates the size of the DP thymocyte pool
[4–5–18]. We next examined DP thymocyte production from
N3
LacZ/LacZ DN3 progenitors under more stringent competitive
conditions, which can reveal developmental defects not evident at
steady state [5–44]. We therefore reasoned that N3 deficiency
might compromise the ability of DN3 progenitors to compete for
Notch-ligand bearing thymic niches even though N3 was
dispensable for steady state thymopoiesis. To test this idea, we
injected mixtures containing equal numbers of N3
+/+ CD45.1;
CD45.2 and N3
LacZ/LacZ CD45.2 Lin
- BM progenitors into
individual thymic lobes of sub-lethally irradiated wild-type B6
CD45.1 hosts. The contribution of each donor population to the
DP thymocyte pool was assessed 3 weeks later. Thymocytes
derived from both donor genotypes were highly abundant and
most had progressed to the DP and mature CD4 single positive
stages (Fig. 3A, top). However, on average, N3
LacZ/LacZ and wild-
Figure 2. Steady-state thymic immunophenotype and cellularity in N3
LacZ/LacZ mice. (A) CD4 vs CD8 distribution of total thymocytes from
N3
+/+ and N3
LacZ/LacZ mice. Thymocytes were stained with anti-CD4-APC and anti-CD8-PE antibodies and analyzed by flow cytometry. (B) CD117 vs
CD25 distribution of Lin
- DN thymocytes from N3
+/+ and N3
LacZ/LacZ mice. (C) Total thymic cellularity of N3
+/+ (black bars) vs N3
LacZ/LacZ (white bars) of 3
week-old (left) and 10 week-old mice (right). Two-tailed Student T-test analyses: P=1 for 3 week-old N3
+/+ (N=4) vs N3
LacZ/LacZ (N=4) mice, and
P=0.8 for 10 week-old N3
+/+ (N=4) vs N3
LacZ/LacZ (N=5) mice.
doi:10.1371/journal.pone.0024937.g002
Figure 1. N3/LacZ reporter expression in DN3 thymocytes. (A) Lin- DN thymocytes from N3LacZ/LacZ and N3+/+ mice were loaded with FDG
and stained with anti-CD25-APC, anti-CD71-biotin, and anti-CD117-APCCy7 followed by Avidin-PECy5. Top: Left plot shows FSC vs CD25 distribution
of CD117- DN thymocytes from N3LacZ/LacZ mice. CD25+ DN3 thymocytes (rectangular gate) were gated to display N3/LacZ vs CD71 (middle) and
FSC versus CD71 (right). Rectangles in the middle and right plots show gates used to define DN3a (CD71lo), and DN3b (CD71hi) subsets. Bottom:
Histograms show N3/LacZ reporter expression in DN3a and DN3b thymocytes from N3LacZ/LacZ mice (open histograms) compared to background
FITC autofluorescence in each N3+/+ subset (shaded histograms). Numbers in each plot depict the average ratio of FITC median fluorescence
intensity from N3LacZ/LacZ mice divided by FITC median intensity of the same subset from N3+/+ mice. Numbers in brackets are the standard
deviation of this measurement (N=3 per genotype). (B) Surface expression of N3 protein on DN thymocytes. Open histograms depict anti-N3-PE
staining on DN1 (CD117
+ CD25
2), DN2 (CD117
+ CD25
+), DN3 (CD117
2 CD25
+), and DN4 (CD117
2 CD25
2) thymocytes from N3
+/+ (top), N3
LacZ/+
(middle) and N3
LacZ/LacZ (bottom) mice compared to ‘‘fluorescence minus one’’ controls generated by staining N3
+/+ thymocytes with all antibodies
except anti-N3-PE (shaded histograms). These experiments were repeated twice showing similar results.
doi:10.1371/journal.pone.0024937.g001
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mature CD4
+ and CD8
+ thymocyte pools (data not shown).
We considered the possibility that robust proliferation of DN1
andDN2progenitorsderivedfrom Lin
2 BMdonorsmightgenerate
enough DN3 progenitors to saturate Notch ligand-bearing niches
before N3 expression was fully induced. Therefore we repeated the
competitive repopulation assay using DN3 progenitors purified
from N3
LacZ/LacZ CD45.2 and N3
+/+ CD45.1; CD45.2 donors. Equal
mixtures of the two donor DN3 populations were intrathymically
injected into sub-lethally irradiated B6.CD45.1 hosts. Because we
started with more developmentally advanced progenitors, the
injected mice were analyzed after 1 week, a time-point previously
shown to yield maximal repopulation from DN3 progenitors [45].
Once again, both genotypes contributed equally to the donor-
Figure 3. Normal competitive fitness of N3
LacZ/LacZ T cell progenitors. (A) Equal mixtures of Lin
- BM progenitors from N3
+/+ and N3
LacZ/LacZ
donors were co-injected intrathymically into sub-lethally irradiated B6.CD45.1 hosts (10
5 cells/thymic lobe). Three weeks later, thymocytes were
stained with anti-CD45.1-PECy7, anti-CD45.2-FITC, anti-CD4-APC and anti CD8-PE and analyzed by flow cytometry. Top: Representative example
showing CD45.1 vs CD45.2 distribution of total thymocytes and CD4 vs CD8 distributions of CD45.1
+ CD45.2
+ (N3
+/+) and CD45.2
+ (N3
LacZ/LacZ) donor-
derived thymocytes. Bottom: Relative contribution of N3
+/+ (black bars) vs N3
LacZ/LacZ (white bars) to the DP thymocyte population in individual
thymic lobes. Two-tailed Student T-test of the relative contribution of N3
+/+ vs N3
LacZ/LacZ donors showed no significant difference (P=0.95). (B) Equal
mixtures of DN3 progenitors sorted from N3
+/+ and N3
LacZ/LacZ mice were co-injected intrathymically into sub-lethally irradiated B6.CD45.1 hosts (10
5
cells/lobe). One week later, thymocytes were stained and analyzed by flow cytometry as described for Figure 3A. Top: Representative example
showing CD45.1 vs CD45.2 distribution of total thymocytes and CD4 vs CD8 distributions of N3
+/+ and N3
LacZ/LacZ donor-derived thymocytes. Bottom:
Bar graph depicts relative contribution of N3
+/+ (black bars) vs N3
LacZ/LacZ (white bars) to the DP thymocyte population of individual thymic lobes.
Two-tailed Student T-test of the relative contribution of N3
+/+ vs N3
LacZ/LacZ donors showed no significant difference (P=0.94). This experiment was
repeated twice with similar results.
doi:10.1371/journal.pone.0024937.g003
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compromise the ability of DN3 progenitors to access Notch ligand-
bearing intrathymic niches under competitive conditions.
No evidence for N3 co-operation with N1 during b-selection
The normal generation of DP thymocytes from of N3
LacZ/LacZ
DN3 progenitors under steady state and competitive conditions
may reflect potent compensation by N1. Similar N1 compensation
for N4 deficiency has been reported [46]. To formally evaluate
functional redundancy or cooperation between N1 and N3, we
intercrossed N1
+/2 and N3
LacZ/LacZ mice to generate compound
mutants. We hypothesized that if N1 and N3 play partially
redundant or co-operative roles in T cell development, then N1
+/2
N3
LacZ/LacZ mice should show a more severe steady state defect
Figure 4. No Evidence for N1-N3 Cooperation during b-selection. (A) Effect of reduced N1 gene dosage on steady state thymocyte and
splenic T cell numbers in N3
LacZ/LacZ mice: Left bar graph shows mean total thymic cell counts from N1
+/+ N3
+/+ (grey, N=3), N1
+/2 N3
LacZ/+ (white,
N=4), N1
+/+ N3
LacZ/LacZ (hatched, N=4), and N1
+/2 N3
LacZ/LacZ (black, N=6) mice at 6 weeks of age. Two-tailed Student’s T-test comparisons gave P
values ranging from 0.2–1 for all pair-wise comparisons. Right bar graph shows average number of TCRb
+ splenic T cells at 6–8 weeks of age in N1
+/+
N3
+/+ (white, N=3), N1
+/+ N3
LacZ/LacZ (blue, N=4), and N1
+/2 N3
LacZ/LacZ (black, N=6) mice. Two-tailed Student’s T-test comparisons: N1
+/+ N3
+/+ vs
N1
+/+ N3
LacZ/LacZ (P=0.6), N1
+/+ N3
LacZ/LacZ vs N1
+/2 N3
LacZ/LacZ (P=0.4), and N1
+/+ N3
LacZ/LacZ vs N1
+/2 N3
LacZ/LacZ (P=0.6). (B) N3 does not compensate
for lower N1 gene dose in N1
+/2 thymocytes. Top: Equal mixtures of N1
+/2 N3
+/+ CD45.1;CD45.2 (black bars) and N1
+/2 N3
+/+ CD45.2 (white bars) DN3
progenitors co-injected intrathymically into sub-lethally irradiated B6.CD45.1 hosts. One week later, cells from each thymic lobe were stained with
anti-CD45.1-PECy7, anti-CD45.2-FITC, anti-CD4-Pacific Blue and anti CD8-PE and analyzed by flow cytometry. The average ratio of CD45.1
+ CD45.2
+ to
CD45.2
+ DP progeny was 1.660.2. Bottom: Equal mixtures of N1
+/2 N3
+/+ CD45.1;CD45.2 (black bars) and N1
+/2 N3
LacZ/LacZ CD45.2 (dashed bars) DN3
progenitors were co-injected intrathymically into sub-lethally irradiated B6.CD45.1 host. One week later, flow cytometry analysis of each lobe shows
that the average ratio of CD45.1
+ CD45.2
+ to CD45.2
+ DP progeny was 1.560.2. Two-tailed Student T-test comparison of the ratios from each type of
competition: (P=0.5). The experiment was performed three times yielding similar results.
doi:10.1371/journal.pone.0024937.g004
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+/2 N3
LacZ/+ or N1
+/+
N3
LacZ/LacZ mutants. However, at steady state there was no
significant difference in thymus cellularity or splenic T cell
abundance in N1
+/2 N3
LacZ/LacZ mice relative to either N1
+/2
N3
LacZ/+ or N1
+/+ N3
LacZ/LacZ littermate controls (Fig. 4A).
Previous studies have shown that N1
+/2 T cell progenitors show
compromised production of DP thymocytes when placed in
competition with wild-type N1
+/+ progenitors [5–11]. We reasoned
that a rolefor N3 in b-selection might be moreobvious when N1gene
dose is limiting. To test this notion we generated compound N1
+/2
N3
LacZ/LacZ mutants, and carried out competition experiments with
equal mixtures of N1
+/2 N3
LacZ/LacZ CD45.2 and N1
+/2 N3
+/+
(CD45.1; CD45.2) DN3 progenitors. Thus in this scenario, both
donor subsets were N1 heterozygous but they differed in N3 gene
dose. For this experiment, control competitions were performed with
equal mixtures of N1
+/2 N3
+/+ (CD45.2) plus N1
+/2N3
+/+(CD45.1;
CD45.2) DN3 cells. The average ratio of DP progeny derived from
the 2 donors was 1.660.2 in the control competitions (Fig. 4B, top).
Importantly, this ratio was not significantly different (p=0.5) from the
ratio of 1.560.2 derived from competitions between N1
+/2 N3
LacZ/
LacZ and N1
+/2 N3
+/+ donors (Fig. 4B, bottom). These data
demonstrate that N3 does not compensate for limiting N1 gene dose
during b-selection, even under stringent competitive conditions.
N3 is dispensable for ICN1-induced T cell leukemogenesis
Previous studies have shown that transgenic mice expressing
ligand-independent mutant ICN3 in DN3 and pre-DP thymocytes
under control of the Lck proximal promoter develop T-LL [30–
Figure 5. N3
+/+ Lck-Cre
+ R26-ICN1
lox/+ mice develop transplantable T-LL. (A) Infiltration of lymphoid organs in moribund N3
+/+ Lck-Cre
+ R26-
ICN1
lox/+ mouse by eGFP
+ TCRb
+ lymphoblasts. Cells were isolated from various lymphoid organs and stained with anti-TCRb-PECy7 antibody. Plots
depict eGFP vs. TCRb-PECy7 in thymus (left), bone marrow (middle) and spleen (right). (B) Hematoxylin and eosin stained liver sections from N3
+/+;Lck-
Cre
2;R 26-ICN1
lox/+ (left) and moribund N3
+/+; Lck-Cre
+; R26-ICN1
lox/+ (right) mice showing dark aggregates of leukemic lymphoblasts around hepatic
vessels. (C) eGFP
+ TCRb
+ lymphoblasts were sorted from spleens and lymph nodes of moribund N3
+/+ Lck-Cre
+ R26-ICN1
+ mice and intravenously
injected into sub-lethally irradiated RAG2
2/2 mice. After two weeks, cells from the indicated organs were isolated and stained with anti-TCRb-PECy7,
anti-CD4-Pacific Blue and anti-CD8-eFluor650 antibodies. TCRb vs. eGFP plot shows infiltration of bone marrow (left) and spleen (middle) with eGFP
+
cells in host RAG2
2/2 recipient mice. Plot on the left shows CD8 vs. CD4 distribution gated on eGFP
+ cells in the spleen.
doi:10.1371/journal.pone.0024937.g005
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human T-LL cells [35–36]. To determine if N3 is required for
ICN1-induced T cell leukemogenesis, we used mice that harbor a
ligand-independent constitutively active ICN1 allele knocked into
the R26 locus [38]. This ICN1 allele is preceded by a lox-stop-lox
sequence and is followed by an IRES and eGFP cDNA. Based on
studies of GFP expression in Cre reporter mice, Lck-Cre activity is
robust in DN3 thymocytes but not prior to that developmental
stage [47]. As expected [24–25], targeting ICN1 to DN3
thymocytes caused R26-ICN1
lox/+;Lck-Cre
+ mice to become mor-
ibund due to development of T-LL. Clinical signs of T-LL
included splenomegaly and enlarged lymph nodes. Lymphoid
tissues and BM were highly infiltrated with eGFP
+ TCRb
+
lymphoblasts (Fig. 5A). Histological analyses also revealed
extensive infiltration of liver by leukemic lymphoblasts (Fig. 5B).
Importantly, eGFP
+ TCRb
+ could adoptively transfer T-LL to
immune-deficient RAG2
2/2 mice (Fig. 5C).
To determine if N3 contributes to ICN1-induced T-LL in this
model, we evaluated T-LL induction in N3
+/+ R26-ICN1
lox/+;Lck-
Cre
+ vs N3
LacZ/LacZ R26-ICN1
lox/+;Lck-Cre
+ mice. N3
+/+ R26-
ICN1
lox/+;Lck-Cre
+ mice developed T-LL with a median latency
of 109616.1 days (Fig. 6A). Importantly, N3-deficiency did not
impair this process, since N3-deficient R26-ICN1
lox/+;Lck-Cre
+
mice developed clinical signs of T-LL with a similar median
latency of 97617.3 days (P=0.4). Furthermore, clinical features
of T-LL lacking N3 were indistinguishable from those seen in
Figure 6. N3 is dispensable for ICN1-induced T cell leukemogenesis. (A) Kaplan-Meier survival curve for N3
+/+ R26-ICN1
lox/+;Lck-Cre
2 (closed
squares), N3
+/+ R26-ICN1
lox/+;Lck-Cre
+ (closed triangles), and N3
LacZ/LacZ R26-ICN1
lox/+;Lck-Cre
+ (open circles) mice over 200 days. Two-tailed Student T-
test comparison between the latter two strains showed no statistically significant difference (P=0.4). (B) Lymphoid organ infiltration by leukemicT
cell blasts in a moribund N3
LacZ/LacZ R26-ICN1
lox/+;Lck-Cre
+ mouse, analyzed as described in Fig. 5. (C) Hematoxylin and eosin stained liver section from
N3
LacZ/LacZ R26-ICN1
lox/+;Lck-Cre
+ mouse shows dark aggregates of leukemic lymphoblasts around hepatic vessels.
doi:10.1371/journal.pone.0024937.g006
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+/+ R26-ICN1
lox/+;Lck-Cre
+ mice (Fig. 6B, C). Based on these
findings, we conclude that N3 is dispensable for N1-induced
leukemogenesis.
Differential binding of DL4 by N1 and N3
DL4 acts non-redundantly to promote T lineage specification at
early stages of T cell development [6–7]. Although N2 is expressed
in early T cell progenitors, it cannot compensate for the
developmental defects caused by N1 deficiency [29]. The ability
of N1 but not N2 to promote T cell development in vivo has been
attributed to the more robust avidity of N1 for DL4, as assessed by
measuring binding of DL4-Fc fusion protein to transiently
transfected N1 vs N2 [29]. We speculated that the failure of N3
deficiency to impact thymocyte b-selection or ICN1-induced T
cell leukemogenesis might indicate that N3 is not efficiently
activated by DL4. Consistent with this notion, we found that N3
deficiency did not impair the ability of DN3 progenitors to
proliferate and differentiate into DP thymocytes after co-culture
with OP9-DL4 stromal cells in vitro (Fig. 7). This finding suggests
that N3 does not significantly contribute to DL4-induced b-
selection in DN3 and pre-DP progenitors.
We hypothesized that the failure of N3 deficiency to impact
DL4-induced b-selection might reflect poor binding of DL4 to N3.
To test this possibility, we compared the ability of N1 and N3 to
bind DL4-Fc fusion protein using a transient transfection assay
[29]. 293T cells showed slightly higher binding of DL4-Fc than the
control Fc protein, indicating expression of endogenous Notch
receptors (Fig. 8A, left). However, we observed 6-fold greater
binding of DL4-Fc to N1-GFP transfected cells relative to GFP
transfected cells, indicating that N1 over-expression greatly
enhances DL4-Fc binding to 293T cells, as expected based on a
previous study [29]. In contrast, N3-Myc + GFP transfected cells
showed similar levels of DL4-Fc binding to control GFP-
transfected 293T cells (Fig. 8A, right). We validated expression
of transfected human N3 protein by surface staining and
immunoblotting (Fig. 8B). Therefore, these data suggest that N3
has a much lower binding affinity for DL4 than N1. In light of
these findings, we suggest that the failure of N3 to compensate for
Figure 7. Effect of N3 deficiency on DL4-induced b-selection in vitro. N3
LacZ/LacZ DN3 thymocytes show normal DL4-induced proliferation and
differentiation in vitro. DN3 thymocytes from either N3
+/+ or N3
LacZ/LacZ mice were co-cultured with OP9-DL4 stromal cells for 3 or 6 days. At each time
point, viable cell counts were determined and cultures were stained with anti-CD4-APC and anti-CD8-PE antibodies. Top: Representative CD4 vs CD8
plots from 6-day progeny of N3
+/+ (left) and N3
LacZ/LacZ (right) DN3 thymocytes. Bottom: Fold-expansion of N3
+/+ (white bars) and N3
LacZ/LacZ (black
bars) DN3 thymocytes co-cultured with OP9-DL4 on day 3 (left, P=0.8) and day 6 (right, P=0.7).
doi:10.1371/journal.pone.0024937.g007
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inefficient N3 activation by intrathymic DL4.
Discussion. The aim of this study was to determine if N3
signaling is required during thymocyte b-selection or during N1-
induced T cell leukemogenesis. We utilized N3/LacZ ‘‘knock-in’’
reporter mice that lack detectable N3 mRNA [39] and showed
that they lack N3 protein. The N3/LacZ reporter as well as N3
protein was highly expressed in N3
+/+ DN3 progenitors, in
agreement with studies on N3 mRNA expression [15–41].
Nonetheless, we observed no impact of N3 deficiency on
thymocyte b-selection at steady state or under more stringent
competitive repopulation experiments. In contrast, DN3
competitive fitness was severely impaired by loss of only one
N1 allele. However, N3 deficiency did not further decrease the
ability of N1
+/2 DN3 progenitors to compete for Notch ligand
niches in the thymus. Thus, although N3 is highly expressed in
DN3 thymocytes, its loss had no impact on b-selection, even
when N1 was limiting. Collectively, these findings demonstrate
that N3 is not needed to signal coincidently with or downstream
of N1 during b-selection. Thus, ligand-activated N1 plays a
unique role in this important developmental process. In addition,
our data demonstrate that N3 is not required for development of
ICN1-induced T-LL. Development of T-LL in Ikaros mutant mice
is characterized by somatic acquisition of activating ICN1
mutations, but a recent study showed that T cell
leukemogenesis in this model is also unaffected by N3
deficiency [48]. Collectively, these data reveal that N3 co-
operation with N1 is dispensable for both T cell development and
T cell leukemogenesis.
In contrast to N1 and N2, N3 is not required for embryogenesis
[49]. However, in post-natal mice N3 critically regulates
differentiation of vascular smooth muscle cells [50]. Indeed, N3
mutations cause CADASIL, an autosomal dominant disease
characterized by recurrent subcortical ischemic events and
vascular dementia [51]. N3 also plays a role in other vascular
pathologies [52–53] and has been implicated in some epithelial
malignancies [54–55]. The clear involvement of N3 in a variety of
human diseases makes it an attractive therapeutic target [54–56].
Our data suggest that selective inhibition of N3 activation for
therapeutic purposes is unlikely to disrupt normal T cell
development.
Why does N3 loss-of-function have no impact on thymocyte b-
selection and ICN1-induced T cell leukemogenesis? The fact that
over-expression of ligand-independent ICN3 can impact b-
selection and drive T cell leukemogenesis [30] suggests that at
least under these non-physiological circumstances, ICN3 can
activate expression of ICN1 gene targets. However, our data
suggest that N3 may not normally undergo ligand-dependent
activation in the thymus. DL4, which is much more abundant
than DL1 in the thymus, binds N1 strongly [29] and is non-
Figure 8. Comparison of DL4 binding to N1 versus N3. 293T cells were transiently transfected with plasmids encoding GFP, N1-GFP
or N3-Myc+GFP. (A) After 72 hrs, transfectants were incubated with control hFc vs DL4-Fc fusion proteins followed by PE-conjugated anti-human Fc
antibody and evaluated by flow cytometry. Histograms show PE fluorescence of live single GFP
+ cells. Left: DL4-Fc binding to 293T cells transfected
with GFP alone (dashed line) versus N1-GFP transfectants (dotted line). Control hFc binding to N1-GFP transfectants (dark grey, filled) is also shown
for comparison. Right: DL4-Fc binding to GFP (dashed line) versus N3-Myc+GFP transfectants (solid line). Control hFc binding to N3-Myc+GFP
transfectants (light grey, filled) is also shown. The median fluorescence intensity ratio of DL4-Fc staining for N1-GFP/GFP DL4-Fc (left) and N3-
Myc+GFP/GFP (right) transfectants are shown in the upper left of each plot. (B) Validation of N3-Myc expression in N3-Myc+GFP 293T transfectants.
293T cells transfected with the indicated plasmids were evaluated after 72 hrs for human N3 expression by flow cytometry and immunoblotting.
Histograms show PE fluorescence from GFP transfectants (left) or N3-Myc+GFP transfectants (middle) unstained (dark grey, filled) versus stained with
PE-conjugated anti-human N3 antibody (black line). All histograms were pre-gated to show live single GFP
+ cells. Right: Lysates from the indicated
transfectants were immunoblotted with anti-human c-Myc (top) and b-actin (bottom) antibodies. The expected molecular weight of Myc-tagged
human N3 is 230 kDa versus 42 kDa for b-actin.
doi:10.1371/journal.pone.0024937.g008
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commitment [6–7]. In contrast to the robust binding of DL4 by
N1, we showed that N3 binds DL4 poorly. This finding suggests
that N3 may not be efficiently activated by intrathymic DL4,
although verification of this possibility awaits the development of
reagents capable of detecting nuclear ICN3 in DN3 and pre-DP
thymocytes.
Interestingly, reporter assays using promoters from different
Notch target genes have demonstrated that N1 and N3 do not
have identical transcriptional activities [57]. Furthermore, al-
though N1 and N3 induce expression of many genes in common,
N1 typically induces more robust expression [58]. Interestingly,
ICN1 prefers closely spaced paired CSL binding sites, whereas
ICN3 prefers single CSL sites with zinc finger transcription factor
sites nearby [59]. ICN1 dimers co-operatively bind CSL paired
sites [60], and importantly, ICN1 dimerization is required for both
T cell development and leukemogenesis [61]. Thus, even if N3 is
weakly activated by intrathymic DL4, it is not clear how efficiently
physiologically expressed ICN3 would induce expression of critical
N1 target genes regulated by paired CSL sites, such as Hes-1, Ptcra
and c-myc. Collectively, our finding that N3 binds DL4 poorly,
combined with subtly different target site preferences for ICN1 vs
ICN3 likely explain why N3 is dispensable for thymocyte b-
selection, even when N1 is limiting.
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